LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
George, S. Elizabeth; Nelson, Gail M. (2011)
Publisher: Microbial Ecology in Health and Disease
Journal: Microbial Ecology in Health and Disease
Languages: English
Types: Article
Subjects:
Following the release of biotechnology agents, detection methods for monitoring human exposure to these microorganisms should be available. Enzymatic markers from chromosomal (lacZY) and plasmid (xylE) DNA were evaluated in an in vivo mouse model. Mice were treated orally or intranasally with Pseudomonas aureofaciens 3732RN-L11 (lacZY), 3732RN-L11::pRO1940 (lacZY xylE), or ATCC 13985. All strains were cleared within 5 days from the cecum or lungs. Direct plating, without intermediate antibiotic resistance selection, was used to detect the genetic markers. Chromosomal-linked lacZ was stable in vivo and in vitro but plasmid-linked xylE was not. Of the isolates recovered, 75% (in vivo, oral), 98% (in vivo, intranasal), and 16% (in vitro) remained XyIE+. Though more tedious to enumerate, both lacZY and xylE are plausible alternatives to antibiotic resistance markers for in vivo biotechnology risk assessment studies.Keywords: Biotechnology Risk Assessment, Pseudomonas aureofaciens, Colonization in vivo.

Share - Bookmark

Cite this article

Collected from